Thomas Franch
CSO
Microbiology
Biotech Umea
Sweden
Biography
Dr. Thomas Franch joined Nuevolution in 2001 as project manager working with novel encoding technologies. From 2006 he served as Chief Technology Officer and Director of Biology heading the company’s technology development efforts and managing several industry partnerships. He was appointed Chief Scientific Officer in 2012. Prior to joining Nuevolution, he co-founded RNA Tech Aps providing rational design and kinetic improvements to antisense therapeutics. Dr. Franch holds a Ph.D. in Molecular Biology from the department of Biochemistry and Molecular Biology (BMB) at the University of Southern Denmark (SDU).
Research Interest
Microbiology
